ARQT icon

Arcutis Biotherapeutics
ARQT

Overview Fund Activity

134 hedge funds and large institutions have $357M invested in Arcutis Biotherapeutics in 2023 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 54 increasing their positions, 37 reducing their positions, and 18 closing their positions.

Holders
134
Holders Change
-2
Holders Change %
-1.47%
% of All Funds
2.14%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
18
Increased
54
Reduced
37
Closed
18
Calls
$688K
Puts
$3.77M
Net Calls
-$3.08M
Net Calls Change
-$4.53M

Top Buyers

1
SCM
1
Sio Capital Management
New York
$3.38M
2
Millennium Management
2
Millennium Management
New York
$1.64M
3
WP
3
Woodline Partners
California
$5.86M
4
SCM
4
Suvretta Capital Management
New York
$6.03M
5
Vanguard Group
5
Vanguard Group
Pennsylvania
$15.3M

Top Sellers

1
CAM
1
Cormorant Asset Management
Massachusetts
$0
2
Fidelity Investments
2
Fidelity Investments
Massachusetts
$43.9M
3
State Street
3
State Street
Massachusetts
$23.2M
4
Axa
4
Axa
France
$0
5
Ameriprise
5
Ameriprise
Minnesota
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
BAAM
151
Baker Avenue Asset Management
California
– -$248 -26 Closed
3 4 5 6
7